Alnylam Pharmaceutical Manufacturing Facility

State-of-the-art Biopharmaceutical manufacturing facility built through design-assist partnering

Alnylam’s state-of-the-art manufacturing facility provides a modular and reproducible approach for development and commercialization RNAi therapies. It is comprised of both small scale and large scale GMP manufacturing suites, a supporting tank farm, modularized central utility plant, GMP storage warehouse with loading dock, and a two-story quality control and administration space. Intense BIM and trade contractor coordination amongst Gilbane, Jacobs architects and MEP staff, along with a variety of key trades took place onsite in the trailer conference rooms.

Photo Credit: Anton Grassi Professional Photos

Gallery

01 / 07
\

Project Overview

  • VDC team modeled 100+ complex distinct systems and over $1 million prefabricated skids
  • The team coordinated extensive prefabricated process piping to run clean and dirty process piping throughout the facility in nine 40-foot-long, 20-foot high elevated tracts that circulate throughout the entire facility
  • Clean portion of the pipe racks include WFI (water for injection) which is high quality, cell culture grade water that complies with United States Pharmacopoeia monographs

205,000

square feet

100+

complex distinct systems modeled

Let’s discuss your next project and achieving your goals.

Ask us about our services and expertise.